Bronchiectasis is a histopathological description of an alteration in the architecture of the bronchi and the development of symptoms is related to the onset of infection.' Before the advent of antibiotic therapy, patients with bronchiectasis tended to produce copious quantities of foul and foetid sputum. However, improvements in oral hygiene and the ready availability of antimicrobial drugs has changed this picture. Symptoms of dyspnoea and wheeze are frequent in bronchiectasis and have been related to the development of chronic bronchitis.
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The composition of the ground substance of the sputum has been found by us to be related to the diagnosis in some chest diseases.2 3 In the present investigation we examined the soluble proteins of sputum specimens from a series of patients with clinically proven bronchiectasis to see whether the composition of the sol or continuous phase of sputum can be a guide to the existence of bronchiectasis or the development of chronic bronchitis, or if it can be related to the severity of the disease. Cotes.5 A 24-hour collection of sputum was carried out on each of the patients. All specimens were processed immediately after collection and weighed aliquots of sputum were centrifuged at three and a half hours at 4°C. Quantitative immunoelectrophoresis of the soluble proteins in the sputum sol phase was carried out substantially by the same methods as those described in detail elsewhere. 6 The concentration of the plasma proteins in the specimens of serum from each patient was measured by the techniques employed for determining the concentration of the corresponding proteins in the sol phase of sputum.
Methods

Results
CLINICAL ASSESSMENT
Patients were graded on a simple score on the basis of six indices chosen because they appeared to provide the best basis of discrimination between the individual patients studied. The indices were: the onset of symptoms before the age of 5 years; the presence or absence of dyspnoea when walking quietly on level ground; the presence of pulmonary crackles; the radiological involvement of four or more lobes (for this purpose the lingula was considered as a separate lobe); the presence of airways obstruction, (FEV1/FEV ratio less than 60%) and a history of cigarette smoking. The results of the clinical grading are summarised in table 1. It can be seen that 10 of the patients had relatively mild bronchiectasis (grades 0, 1, or 2) and the remainder had moderately severe or severe bronchiectasis (grades 3, 4, or 5).
IMMUNOCHEMISTRY
Wide variation was encountered when the concentrations of plasma proteins in the sol phase of sputum were measured (table 2) . Patient-topatient variation in sputum sol phase albumin concentrations appeared to follow a progressive type of pattern that was unrelated to clinical grading ( fig 1) . All other plasma protein concentrations, with the exception of IgA (r=0-46, 0 * 05<p<0 * 1) showed significant correlation with the sputum sol phase albumin concentrations. The concentration ratios of albumin in matched specimens of serum and sputum were inversely related to the sputum sol phase albumin concentrations (r=0 95, p<0 0001), and all other protein concentration ratios correlated significantly with the albumin concentration ratio except IgA (r=0 29), a,-antichymotrypsin (r= 0 24), and C3 (r=0-25); the probabilities in each case were 0-2 <p <0 5. The mean concentrations of IgA relative to transferin matched pairs of sputum and serum were 9-51 + 6-03 and 1-49+0 63 (t=5-29, <0 0001) and those of a1-antichymotrypsin in sputum and serum were 4-45 + 3-19 and 1-73 + 142 (t=311; 0.0001 <p <0.0005) thus suggesting selective concentration in sputum of these two plasma proteins. In contrast, the corresponding relative concentrations of C3 in sputum and serum were 3-52 + 1-43 and 2-37 + 0-78 and these differences only just achieved significance (0 025<p<0 05).
Discussion
The patient-to-patient variation in the concentrations of the plasma proteins in the sol phase of the sputum specimens seemed to follow a continuous progression. Although some patients appear to produce sputum resembling that of patients with chronic bronchitis, others at the 
